OL
RPRX icon

Odyssean LLC’s Royalty Pharma RPRX Stock Holding History

Odyssean LLC’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
54,179
+21,401
+65% +$1.11M 0.49% 51
2026
Q1 		$1.57M Buy
32,778
+13,831
+73% +$606K 0.57% 7
2025
Q4 		$732K Buy
+18,947
New +$723K 0.53% 103

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Odyssean LLC's RPRX Position: Q2 2026 in Review

Odyssean LLC increased its Royalty Pharma (RPRX) stake by 65% in Q2 2026, buying an estimated $1.11M and bringing the position to 54,179 shares worth $3.04M. The position accounts for 0.49% of the portfolio, ranked #51.

Odyssean LLC first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 640 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Odyssean LLC held 54,179 shares of Royalty Pharma worth $3.04M as of Q2 2026.
  • Odyssean LLC bought 21,401 Royalty Pharma shares in Q2 2026, an estimated $1.11M.
  • Royalty Pharma made up 0.49% of Odyssean LLC's portfolio in Q2 2026, its #51 holding.
  • Odyssean LLC first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 640 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.